NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.05
Delayed Data
As of 12:57pm ET
 +0.20 / +7.02%
Today’s Change
2.25
Today|||52-Week Range
5.00
-20.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues4.1M4.1M6.3M2.9M
 
 
 
 
 
Cost of Goods Sold680.0K503.0K936.0K210.0K
 
 
 
 
 
Depreciation And Amortization18.0K18.0K41.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.4M3.6M5.3M2.7M
 
 
 
 
 
General Expenses5.2M5.7M4.9M5.1M
 
 
 
 
 
Research And Development70.0K132.0K146.0K46.0K
 
 
 
 
 
Total Operating Expenses5.9M6.3M5.9M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M-2.2M392.0K-2.4M
 
 
 
 
 
Extraordinary Credit15.0K0.00400.0K214.0K
 
 
 
 
Extraordinary Charge---281.0K0.000.00
 
 
Other Expenses4.0K3.0K3.0K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.7M-2.4M795.0K-2.2M
 
 
 
 
 
Income Taxes0.000.00-2.0K0.00
 
 
Net Income-1.7M-2.4M793.0K-2.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.3M15.3M15.4M16.4M
 
 
 
 
 
Shares To Calculate EPS Diluted15.3M15.3M16.0M16.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.16$0.02-$0.14
 
 
 
 
 
EPS Diluted-$0.11-$0.16$0.05-$0.14